2023 Aug 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
PMID:32644378
Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.
Dervenis P, Dervenis N, Smith JM, Steel DH.
Cochrane Database Syst Rev. 2023 May 31;5(5):CD008214. doi: 10.1002/14651858.CD008214.pub4.
PMID:37260074
Post-vitrectomy delayed retinal breaks in proliferative diabetic retinopathy.
Venkatesh R, Parmar Y, Mangla R, Sharief S, Yadav NK, Chhablani J.
Int J Retina Vitreous. 2023 Feb 1;9(1):7. doi: 10.1186/s40942-023-00444-1.
PMID:36726158
Favorable Anti-VEGF Crunch Syndrome: Nonsurgical Relief of Vitreoretinal Traction in Eyes With Proliferative Diabetic Retinopathy and Tractional Retinal Detachment.
Lee IT, Corona ST, Wong TP, Flynn HW Jr, Wykoff CC.
ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND RISK OF TRACTION RETINAL DETACHMENT IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY: Pooled Analysis of Five DRCR Retina Network Randomized Clinical Trials.